Vaxneuvance (Pneumococcal 15-valent Conjugate Vaccine)

Vaxneuvance (Pneumococcal 15-valent Conjugate Vaccine) is a vaccine used for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals aged 6 weeks and older.

Recommended Dosage: Each dose of Vaxneuvance is 0.5 mL. In children, administer Vaxneuvance as a 4-dose series at 2, 4, 6, and 12 through 15 months of age (and at least 2 months after the third dose). The first dose may be administered as early as six weeks of age. In adults, administer Vaxneuvance as a single dose in adults aged 18 years and older.

• Suitable medical treatment to manage allergic reactions must be promptly available in the event an acute anaphylactic reaction occurs following administration of Vaxneuvance 0.5 mL injection. 
• Some individuals with altered immunocompetence, including those with immunosuppressive therapy, may have a decreased immune response to Vaxneuvance (Pneumococcal 15-valent Conjugate Vaccine).
• Apnea after intramuscular vaccination may occur in some infants born prematurely. A judgment about when to administer it to infants born prematurely must be based on consideration of the medical status of an individual infant and the probable benefits and possible risks of vaccination. 
• Postpone vaccination in those suffering from acute severe febrile illness or acute infection. The presence of low-grade fever and/or a minor infection should not delay vaccination.
• As with other intramuscular (IM) injections, the vaccine needs to be given with caution to those receiving anticoagulant therapy, or to those with thrombocytopenia or any coagulation disorder such as hemophilia. Bruising or bleeding may occur after intramuscular administration in these people.

What documents are required to import VAXNEUVANCE to India?

VAXNEUVANCE (Pneumococcal 15-valent Conjugate Vaccine) can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
  
• Patients diagnostic reports
  
• Patients ID proof (issued by the government of India)

The order will be confirmed only after the receipt of:

• A valid prescription from Doctor
  
• Import permit if applicable

VAXNEUVANCE (Pneumococcal 15-valent Conjugate Vaccine) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Vaxneuvance in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  
• Medicine Price.
  
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  
• Ensuring 100% transparency.

IPN (Indian Pharma Network) can facilitate the supply of VAXNEUVANCE (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Vaxneuvance 0.5 mL price in India. 

We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network is able to source the VAXNEUVANCE (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Vaxneuvance®?

Pneumococcal 15-valent Conjugate Vaccine is a Generic Name for the trade name drug Vaxneuvance®.

What is the Manufacturer’s Name of Vaxneuvance®?

Vaxneuvance® is manufactured by Merck.

Is Vaxneuvance® approved by the FDA?

Yes, Vaxneuvance® is approved by the FDA. Date of first approval: July 16, 2021.

What is the dosage and form of Vaxneuvance® supplied?

Vaxneuvance® is supplied as a suspension for intramuscular injection in a 0.5 mL single-dose prefilled syringe. 

How much does Vaxneuvance® cost in India?

The cost of Vaxneuvance in India can vary. To procure this vaccine legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the storage conditions of Vaxneuvance®?

Store refrigerated at a temperature of 2°C to 8°C (36°F to 46°F). It is not advisable to freeze the vials. Protect vials from light.

Is it safe to buy Vaxneuvance® online in India?

Yes, one can buy Vaxneuvance online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can facilitate the supply of Vaxneuvance through legal channels.